Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy

Biogen Revenue 2006-2018 | BIIB

Current and historical revenue for Biogen (BIIB) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Biogen as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.002B $12.274B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.889B 14.86
Gilead Sciences (GILD) United States $100.185B 9.99
Celgene (CELG) United States $61.857B 12.30
Vertex Pharmaceuticals (VRTX) United States $45.900B 150.10
Illumina (ILMN) United States $45.438B 64.13
Regeneron Pharmaceuticals (REGN) United States $39.604B 23.51
Alexion Pharmaceuticals (ALXN) United States $30.058B 25.02
BioMarin Pharmaceutical (BMRN) United States $18.179B 0.00
Incyte (INCY) United States $14.861B 0.00
Seattle Genetics (SGEN) United States $11.158B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.682B 0.00
Bluebird Bio (BLUE) United States $8.969B 0.00
Sarepta Therapeutics (SRPT) United States $8.881B 0.00
BeiGene (BGNE) Cayman Islands $8.823B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.516B 68.69
QIAGEN (QGEN) Netherlands $8.431B 28.20
Exact Sciences (EXAS) United States $8.242B 0.00
Alkermes (ALKS) Ireland $7.020B 0.00
Exelixis (EXEL) United States $6.335B 25.71
Bio-Techne Corp (TECH) United States $5.782B 39.66
Integra LifeSciences Holdings (IART) United States $5.556B 29.82
Galapagos (GLPG) Belgium $5.299B 0.00
Ligand Pharmaceuticals (LGND) United States $4.953B 66.44
Immunomedics (IMMU) United States $4.351B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $4.269B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.176B 0.00
Array BioPharma (ARRY) United States $3.598B 0.00
China Biologic Products (CBPO) China $3.372B 22.27
Spark Therapeutics (ONCE) United States $3.069B 0.00
Myriad Genetics (MYGN) United States $3.058B 37.08
Amicus Therapeutics (FOLD) United States $3.012B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.993B 0.00
Medicines (MDCO) United States $2.950B 0.00
Ascendis Pharma (ASND) Denmark $2.942B 0.00
Horizon Pharma Public (HZNP) Ireland $2.865B 17.53
Intercept Pharmaceuticals (ICPT) United States $2.832B 0.00
Blueprint Medicines (BPMC) United States $2.799B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.755B 0.00
Emergent Biosolutions (EBS) United States $2.724B 34.82
Halozyme Therapeutics (HALO) United States $2.591B 40.00
Akcea Therapeutics (AKCA) United States $2.589B 0.00
REGENXBIO (RGNX) United States $2.534B 58.78
Clovis Oncology (CLVS) United States $2.472B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.324B 0.00
Arena Pharmaceuticals (ARNA) United States $2.191B 0.00
Global Blood Therapeutics (GBT) United States $2.148B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.132B 0.00
Repligen (RGEN) United States $2.132B 67.76
Acceleron Pharma (XLRN) United States $2.119B 0.00
Genomic Health (GHDX) United States $2.063B 364.44
MyoKardia (MYOK) United States $2.002B 0.00
Puma Biotechnology (PBYI) United States $1.983B 0.00
Insmed (INSM) United States $1.922B 0.00
Cambrex (CBM) United States $1.836B 16.88
AnaptysBio (ANAB) United States $1.733B 0.00
Atara Biotherapeutics (ATRA) United States $1.727B 0.00
Editas Medicine (EDIT) United States $1.708B 0.00
Aimmune Therapeutics (AIMT) United States $1.697B 0.00
Solid Biosciences (SLDB) United States $1.564B 0.00
Sangamo Therapeutics (SGMO) United States $1.527B 0.00
G1 THERAPEUTICS (GTHX) United States $1.527B 0.00
Audentes Therapeutics (BOLD) United States $1.494B 0.00
IMMURON LTD (IMRN) Australia $1.483B 0.00
Mirati Therapeutics (MRTX) United States $1.482B 0.00
Innoviva (INVA) United States $1.454B 10.66
BIOHAVEN PHARM (BHVN) United States $1.416B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.387B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.382B 0.00
Acorda Therapeutics (ACOR) United States $1.372B 0.00
Intellia Therapeutics (NTLA) United States $1.363B 0.00
Denali Therapeutics (DNLI) United States $1.322B 0.00
UniQure (QURE) Netherlands $1.320B 0.00
Myovant Sciences (MYOV) United Kingdom $1.317B 0.00
Lion Biotechnologies (IOVA) United States $1.313B 0.00
Cellectis (CLLS) France $1.252B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.242B 0.00
Retrophin (RTRX) United States $1.236B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.223B 0.00
Reata Pharmaceuticals (RETA) United States $1.215B 0.00
Athenex (ATNX) United States $1.184B 0.00
NeoGenomics (NEO) United States $1.133B 234.17
Coherus BioSciences (CHRS) United States $1.128B 0.00
Intra-Cellular Therapies (ITCI) United States $1.128B 0.00
WAVE Life Sciences (WVE) Singapore $1.110B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.092B 0.00
Revance Therapeutics (RVNC) United States $1.061B 0.00
Apellis Pharmaceuticals (APLS) United States $1.040B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.034B 0.00
DBV Technologies (DBVT) France $0.988B 0.00
Dynavax Technologies (DVAX) United States $0.975B 0.00
CytomX Therapeutics (CTMX) United States $0.955B 0.00
Epizyme (EPZM) United States $0.942B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.906B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.902B 0.00
ANI Pharmaceuticals (ANIP) United States $0.832B 17.04
AC Immune SA (ACIU) Switzerland $0.821B 0.00
Heska (HSKA) United States $0.815B 62.47
Amarin (AMRN) Ireland $0.810B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.806B 0.00
AVROBIO (AVRO) United States $0.799B 0.00
InflaRx (IFRX) Germany $0.787B 0.00
Sorrento Therapeutics (SRNE) United States $0.785B 0.00
Eidos Therapeutics (EIDX) United States $0.770B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.760B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.757B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.728B 0.00
Abeona Therapeutics (ABEO) United States $0.672B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.671B 0.00
Kura Oncology (KURA) United States $0.670B 0.00
Aptinyx (APTX) United States $0.662B 0.00
UROGEN PHARMA (URGN) Israel $0.660B 0.00
UNITY Biotechnology (UBX) $0.640B 0.00
Cara Therapeutics (CARA) United States $0.630B 0.00
Arbutus Biopharma (ABUS) Canada $0.629B 0.00
Viking Therapeutics (VKTX) United States $0.625B 0.00
Mesoblast (MESO) Australia $0.619B 0.00
Tigenix (TIG) Belgium $0.605B 0.00
Five Prime Therapeutics (FPRX) United States $0.604B 0.00
ObsEva SA (OBSV) Switzerland $0.603B 0.00
Geron (GERN) United States $0.602B 0.00
Prothena (PRTA) Ireland $0.599B 0.00
Fate Therapeutics (FATE) United States $0.586B 0.00
BeyondSpring (BYSI) United States $0.579B 0.00
Senesco Technologies (ELOX) United States $0.578B 0.00
Aduro Biotech (ADRO) United States $0.555B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.554B 0.00
Novavax (NVAX) United States $0.542B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.541B 0.00
Merus (MRUS) Netherlands $0.538B 0.00
Arcus Biosciences (RCUS) United States $0.537B 0.00
Anika Therapeutics (ANIK) United States $0.503B 19.95
Stemline Therapeutics (STML) United States $0.503B 0.00
Magenta Therapeutics (MGTA) United States $0.487B 0.00
Cytokineticsorporated (CYTK) United States $0.482B 0.00
Evelo Biosciences (EVLO) United States $0.470B 0.00
Zealand Pharma (ZEAL) Denmark $0.470B 0.00
Verastem (VSTM) United States $0.466B 0.00
MiMedx (MDXG) United States $0.446B 19.14
Zymeworks (ZYME) Canada $0.446B 0.00
Sinovac Biotech (SVA) China $0.437B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.434B 0.00
Unum Therapeutics (UMRX) United States $0.420B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.412B 0.00
Syros Pharmaceuticals (SYRS) United States $0.393B 0.00
Inovio Pharmaceuticals (INO) United States $0.393B 0.00
Albireo Pharma (ALBO) United States $0.389B 0.00
PDL BioPharma (PDLI) United States $0.384B 3.92
Vericel (VCEL) United States $0.381B 0.00
Scholar Rock Holding (SRRK) United States $0.376B 0.00
MediciNova (MNOV) United States $0.367B 0.00
Kindred Biosciences (KIN) United States $0.362B 0.00
Vital Therapies (VTL) United States $0.358B 0.00
RA PHARMCTL INC (RARX) United States $0.353B 0.00
Cellular Biomedicine (CBMG) United States $0.350B 0.00
GTx (GTXI) United States $0.346B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.339B 0.00
Seres Therapeutics (MCRB) United States $0.336B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.330B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.329B 0.00
Adverum Biotechnologies (ADVM) United States $0.321B 0.00
Clearside Biomedical (CLSD) United States $0.319B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.317B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.316B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.307B 0.00
Kala Pharmaceuticals (KALA) United States $0.306B 0.00
Kezar Life Sciences (KZR) United States $0.302B 0.00
BioTime (BTX) United States $0.299B 0.00
Selecta Biosciences (SELB) United States $0.293B 0.00
Celyad SA (CYAD) Belgium $0.293B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.288B 0.00
MeiraGTx Holdings (MGTX) United States $0.286B 0.00
Athersys (ATHX) United States $0.286B 0.00
Synlogic (SYBX) United States $0.282B 0.00
Axovant Sciences (AXON) United Kingdom $0.277B 0.00
Kadmon Holdings (KDMN) United States $0.270B 0.00
NantKwest (NK) United States $0.267B 0.00
OVID THERAPEUTC (OVID) United States $0.261B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.259B 0.00
Mersana Therapeutics (MRSN) United States $0.258B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.252B 0.00
ResTORbio (TORC) United States $0.245B 0.00
ChromaDex (CDXC) United States $0.243B 0.00
Celcuity (CELC) United States $0.237B 0.00
Agenus (AGEN) United States $0.233B 0.00
Allena Pharmaceuticals (ALNA) United States $0.230B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
Kamada (KMDA) Israel $0.230B 18.39
Cohbar (CWBR) United States $0.228B 0.00
Enzo Biochem (ENZ) United States $0.225B 0.00
Cue Biopharma (CUE) United States $0.223B 0.00
MannKind (MNKD) United States $0.223B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.218B 0.00
XOMA (XOMA) United States $0.210B 15.95
Signal Genetics (MGEN) United States $0.209B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.204B 0.00
Mustang Bio (MBIO) United States $0.203B 0.00
Palatin Technologies (PTN) United States $0.199B 7.69
Erytech Pharma SA Sponsored ADR (ERYP) $0.198B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.194B 0.00
Idera Pharmaceuticals (IDRA) United States $0.189B 0.00
Krystal Biotech (KRYS) United States $0.186B 0.00
TOCAGEN INC (TOCA) United States $0.183B 0.00
VBI Vaccines (VBIV) United States $0.182B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.179B 0.00
Menlo Therapeutics (MNLO) United States $0.178B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.177B 0.00
BioDelivery Sciences (BDSI) United States $0.171B 0.00
NewLink Genetics (NLNK) United States $0.169B 0.00
Monster Digital (INNT) United States $0.169B 0.00
BioXcel Therapeutics (BTAI) United States $0.168B 0.00
Protagonist Therapeutics (PTGX) United States $0.168B 0.00
Spero Therapeutics (SPRO) United States $0.165B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.164B 0.00
Intec Pharma (NTEC) Israel $0.156B 0.00
XBiotech (XBIT) United States $0.156B 0.00
Bellerophon Therapeutics (BLPH) United States $0.154B 0.00
Organovo Holdings (ONVO) United States $0.147B 0.00
Cocrystal Pharma (COCP) United States $0.146B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.145B 0.00
Cerecor (CERC) United States $0.145B 23.10
Pluristem Therapeutics (PSTI) Israel $0.144B 0.00
Anavex Life Sciences (AVXL) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.142B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.139B 0.00
PSivida (EYPT) United States $0.134B 0.00
Pfenex (PFNX) United States $0.132B 0.00
Catalyst Biosciences (CBIO) United States $0.130B 0.00
Motif Bio Plc (MTFB) United States $0.126B 0.00
Leap Therapeutics (LPTX) United States $0.123B 0.00
Cidara Therapeutics (CDTX) United States $0.120B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.114B 0.00
Gemphire Therapeutics (GEMP) United States $0.113B 0.00
Aptevo Therapeutics (APVO) United States $0.112B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.111B 0.00
Aptose Biosciences (APTO) Canada $0.110B 0.00
Tapimmune (TPIV) United States $0.106B 0.00
Trevena (TRVN) United States $0.103B 0.00
GENPREX INC (GNPX) United States $0.102B 0.00
Proteostasis Therapeutics (PTI) United States $0.100B 0.00
Asterias Biotherapeutics (AST) United States $0.096B 0.00
Sophiris Bio (SPHS) United States $0.095B 0.00
Ophthotech (OPHT) United States $0.095B 0.65
Eleven Biotherapeutics (SESN) United States $0.092B 0.00
Alcobra (ARCT) Israel $0.091B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.090B 0.00
Oncolytics Biotech (ONCY) Canada $0.088B 0.00
Checkpoint Therapeutics (CKPT) United States $0.087B 0.00
Orgenesis (ORGS) United States $0.087B 0.00
ScPharmaceuticals (SCPH) United States $0.087B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.085B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.083B 0.00
Axsome Therapeutics (AXSM) United States $0.080B 0.00
VIVUS (VVUS) United States $0.077B 0.00
Advaxis (ADXS) United States $0.076B 0.00
Applied Genetic Technologies (AGTC) United States $0.075B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Celldex Therapeutics (CLDX) United States $0.073B 0.00
Alimera Sciences (ALIM) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.071B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
Histogenics (HSGX) United States $0.070B 0.00
Entera Bio (ENTX) Israel $0.068B 0.00
OncoSec Medical (ONCS) United States $0.067B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
Novelion Therapeutics (NVLN) Canada $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.064B 0.00
Vascular Biogenics (VBLT) Israel $0.063B 0.00
Aileron Therapeutics (ALRN) United States $0.062B 0.00
Neothetics (EVFM) United States $0.061B 0.00
VolitionRX (VNRX) Singapore $0.059B 0.00
Curis (CRIS) United States $0.055B 0.00
Caladrius Biosciences (CLBS) United States $0.054B 0.00
Zosano Pharma (ZSAN) United States $0.052B 0.00
Celsion (CLSN) United States $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.047B 0.00
Moleculin Biotech (MBRX) United States $0.047B 0.00
Arsanis (ASNS) United States $0.045B 0.00
TRACON Pharmaceuticals (TCON) United States $0.045B 0.00
BioPharmX (BPMX) United States $0.044B 0.00
AZURRX BIOPHARM (AZRX) United States $0.044B 0.00
Proteon Therapeutics (PRTO) United States $0.042B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.042B 0.00
CytRx (CYTR) United States $0.041B 0.00
Cellect Biotechnology (APOP) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.039B 0.00
Chiasma (CHMA) United States $0.035B 0.00
OvaScience (OVAS) United States $0.033B 0.00
AEterna Zentaris (AEZS) United States $0.032B 0.00
Edge Therapeutics (EDGE) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
Benitec Biopharma (BNTC) Australia $0.030B 0.00
Vical (VICL) United States $0.029B 0.00
Oncobiologics (ONS) United States $0.028B 0.00
ATyr Pharma (LIFE) United States $0.026B 0.00
Synthetic Biologics (SYN) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
RestorGenex (DFFN) United States $0.023B 0.00
CorMedix Inc (CRMD) United States $0.022B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.021B 0.00
Prana Biotechnology (PRAN) Australia $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Cel-Sci (CVM) United States $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Flex Pharma (FLKS) United States $0.015B 0.00
Cerulean Pharma (DARE) United States $0.015B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 6.03
Alliqua BioMedical (ALQA) United States $0.011B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.010B 0.00
Galena Biopharma (SLS) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.010B 0.00
Soligenix (SNGX) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Immune Pharmaceuticals (IMNP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Oragenics (OGEN) United States $0.004B 0.00
TrovaGene (TROV) United States $0.004B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00